Hematopoietic Stem Cell Transplantation May Not Reduce Renal Function in Sickle Cell Disease
For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.
For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.
Researchers characterized hospitalization and case fatality rates secondary to COVID-19 among individuals with SCD and compared with the general Black population.
Researchers have identified the binding site for LRF as a therapeutic target for β-hemoglobinopathies.
Researchers evaluated the cumulative incidence of intracranial and extracranial arteriopathy and associated risk factors in children with sickle cell disease.
Investigators compared ovarian reserve and assessed clinical characteristics in young women with sickle cell anemia vs those without the condition.